Solenic Medical to Exhibit at the 2024 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) in San Francisco

Picture1-Jan-15-2024-06-09-30-6705-PMSolenic Medical Inc. will be a first time exhibitor (Booth #4142) at The American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting February 12-14th. This is the premier event in the field of orthopaedic surgery, bringing together professionals, researchers, and experts to exchange knowledge and advancements in musculoskeletal care. The meeting features a diverse range of educational sessions, workshops, and presentations covering various orthopaedic specialties, surgical techniques, and emerging technologies like Solenic Medical Alternating Magnetic Field (AMF) based treatment for peri-prosthetic joint infections (PJIs).

Furthermore, Solenic Medical was chosen as one of four finalists to showcase our technology to a panel of industry professionals at the AAOS Orthopitch competition. This is a brand-new technology competition for creative and inventive orthopaedic products, organized by AAOS and foundational sponsor MCRA.


About Solenic Medical

Solenic Medical, Inc. is a medical device company developing an innovative non-invasive treatment for infected metallic implants in the body. Using technology invented at the University of Texas Southwestern, Solenic is leveraging the unique properties of alternating magnetic fields (AMF) generated by external coils to reduce, and possibly eradicate, the biofilm on the surface of metallic implants. This non-invasive, non-contact treatment addresses a major complication frequently associated with various surgeries such as knee and hip replacements, and orthopedic trauma cases requiring plates, rods, and/or nails. The technology is particularly important and timely given the rise in the aging population, longer life expectancy, and the rapid increase in the number of orthopedic procedures being performed every year. Solenic's AMF technology has been designated a Breakthrough Device by the U.S. FDA. It has the potential to completely replace the costly and risky two-step revision surgical procedure, which is the current standard of care for chronic infections on medical implants. Solenic Medical, Inc. is a VIC Technology Venture Development™ portfolio company.